Please Note - Streaming News is only available to subscribers to the Active Level and above
RNS News Service
I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.
Form 8.3 - Willis Towers Watson plc
RNS
RNS Number : 3421C
Citadel Group
16 October 2020
Ap 19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
Citadel Group
Company dealt in
WILLIS TOWERS WATSON PLC
Class of relevant security to which the dealings being disclosed relate (Note 2)
Common Stock ISIN IE00BDB6Q211
Date of dealing
15 October, 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 3)
Long
Short
ISIN IE00BDB6Q211
Number (%)
Number (%)
(1) Relevant securities
269,275 (0.21%)
258 (0.00%)
(2) Derivatives (other than options)
1,638,427 (1.27%)
0 (0.00%)
(3) Options and agreements to purchase/sell
0 (0.00%)
0 (0.00%)
Total
1,907,702 (1.48%)
258 (0.00%)
Ap 20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale
ISIN IE00BDB6Q211
Number of securities
Price per unit (Note 5)
Buy Transaction
9
211.8000 USD
Buy Transaction
200
211.8600 USD
Buy Transaction
100
212.8300 USD
Buy Transaction
8
213.5100 USD
Buy Transaction
5
213.7600 USD
Buy Transaction
583
214.1515 USD
Buy Transaction
1,688
214.3848 USD
Buy Transaction
253
214.5473 USD
Buy Transaction
133
215.4666 USD
Buy Transaction
159
215.8406 USD
Buy Transaction
100
216.1000 USD
Buy Transaction
186
216.1644 USD
Buy Transaction
100
216.2300 USD
Buy Transaction
99
216.6200 USD
Sell Transaction
10
214.1100 USD
Sell Transaction
293
214.8881 USD
Sell Transaction
1,719
215.5333 USD
Sell Transaction
451
215.5889 USD
Sell Transaction
263
215.6361 USD
Sell Transaction
2,944
215.6566 USD
Sell Transaction
3,988
215.6647 USD
Sell Transaction
354
215.6749 USD
Sell Transaction
990
215.7658 USD
Sell Transaction
1,322
215.7851 USD
Sell Transaction
293
215.7851 USD
Sell Transaction
398
215.8077 USD
Sell Transaction
17
215.8482 USD
Sell Transaction
85
215.9640 USD
Sell Transaction
462
215.9695 USD
Sell Transaction
638
215.9695 USD
Sell Transaction
64
215.9717 USD
Sell Transaction
168
215.9737 USD
Sell Transaction
232
215.9737 USD
Sell Transaction
18
216.0589 USD
Sell Transaction
121
216.0804 USD
Sell Transaction
91
216.0852 USD
Sell Transaction
210
216.0852 USD
Sell Transaction
223
216.0860 USD
Sell Transaction
24
216.1200 USD
Sell Transaction
5
216.2700 USD
Sell Transaction
406
216.2936 USD
Sell Transaction
294
216.2936 USD
Sell Transaction
112
216.3146 USD
Sell Transaction
84
216.4200 USD
Sell Transaction
116
216.4200 USD
Sell Transaction
11
216.4600 USD
Sell Transaction
17
216.4700 USD
Sell Transaction
100
216.5300 USD
Sell Transaction
1,155
216.6200 USD
(b) Derivatives transactions (other than options transactions)
Product name,
e.g. CFD
ISIN IE00BDB6Q211
Nature of transaction
(Note 6)
Number of relevant securities
(Note 7)
Price per unit
(Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing,
varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type,
e.g. American, European etc.
Expiry date
Option money paid/ received per unit
(Note 5)
(ii) Exercising
Product name,
e.g. call option
Number of securities
Exercise price per unit
(Note 5)
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction
(Note 8)
Details
Price per unit
(if applicable) (Note 5)
Ap 21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated
None
Is a Supplemental Form 8 attached? (Note 9)
NO
Date of disclosure:
16 October, 2020
Contact name:
Kim Heslop
Telephone number:
020 7645 9700
If a connected EFM, name of offeree/offeror with which connected
n/a
If a connected EFM, state nature of connection (Note 10)
n/a
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.